Brooks Laboratories Ltd Nine Monthly Results

Gross Sales

59.24

61.76

50.51

62.62

62.63

Excise Duty

0

0

0

0

0

Net Sales

59.24

61.76

50.51

62.62

62.63

Other Operating Income

0

0

0

0

0

Other Income

0.26

0.3

0.89

0.73

1.24

Total Income

59.5

62.07

51.4

63.34

63.87

Total Expenditure

66.03

70.14

76.89

73.07

58.18

PBIDT

-6.53

-8.07

-25.49

-9.72

5.69

Interest

0.77

0.57

2

2.25

2.36

PBDT

-7.3

-8.64

-27.49

-11.98

3.33

Depreciation

1.21

1.32

6.59

5.4

5.41

Minority Interest Before NP

0

0

0

0

0

Tax

0

0.03

0

0

0

Deferred Tax

0

0

-7.32

-4

0

Reported Profit After Tax

-8.51

-9.99

-26.76

-13.38

-2.08

Minority Interest After NP

0

0

-10.15

-0.79

0

Net Profit after Minority Interest

-8.51

-9.99

-16.6

-12.58

-2.08

Extra-ordinary Items

0

0

0.36

0

0

Adjusted Profit After Extra-ordinary item

-8.51

-9.99

-16.96

-12.58

-2.08

EPS (Unit Curr.)

-3.24

-3.9

-6.72

-5.09

-0.84

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

26.25

26.25

24.7

24.7

24.7

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-11.02

-13.06

-50.46

-15.52

9.08

PBDTM(%)

-12.32

-13.98

-54.42

-19.13

5.31

PATM(%)

-14.36

-16.17

-52.97

-21.36

-3.32